SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 127 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,644,000 | +68.6% | 109,754 | +36.9% | 0.01% | 0.0% |
| Q1 2016 | $975,000 | -69.4% | 80,154 | -60.0% | 0.01% | -55.0% |
| Q4 2015 | $3,191,000 | +8.7% | 200,554 | +4.8% | 0.02% | +11.1% |
| Q3 2015 | $2,935,000 | -37.4% | 191,454 | -0.8% | 0.02% | -28.0% |
| Q2 2015 | $4,691,000 | -13.6% | 192,954 | -17.4% | 0.02% | -13.8% |
| Q1 2015 | $5,430,000 | -4.6% | 233,554 | +3.1% | 0.03% | 0.0% |
| Q4 2014 | $5,690,000 | -18.6% | 226,600 | +0.8% | 0.03% | -17.1% |
| Q3 2014 | $6,991,000 | +17.9% | 224,800 | -2.0% | 0.04% | +25.0% |
| Q2 2014 | $5,932,000 | -18.7% | 229,400 | -26.5% | 0.03% | -22.2% |
| Q1 2014 | $7,296,000 | +2.6% | 312,200 | +11.4% | 0.04% | 0.0% |
| Q4 2013 | $7,114,000 | – | 280,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |